From: Autoimmune diseases and hypersensitivities improve the prognosis in ER-negative breast cancer
a) BC patients with coexisting AD or HS | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
All patients. N=1508, N=1363 and N=1363. | ||||||||||
HR | 95% CI for HR | p-value | ||||||||
AD-HS, adjusted for: | N | Lower | Upper | |||||||
Age at diagnosis | 194 | 0.88 | 0.71 | 1.10 | 0.25 | |||||
Age at diagnosis, TNM-stage | 185 | 0.91 | 0.72 | 1.14 | 0.409 | |||||
Age at diagnosis, TNM-stage, Screening | 185 | 0.94 | 0.75 | 1.18 | 0.579 | |||||
Patients younger than 65 years at diagnosis of BC. N=1021 | Patients younger than 50 years at diagnosis of BC. N=473 | |||||||||
N | HR | 95% CI for HR | p-value | N | HR | 95% CI for HR | p-value | |||
AD-HS, adjusted for: | Lower | Upper | Lower | Upper | ||||||
Age at diagnosis, TNM-stage | 130 | 0.94 | 0.75 | 1.18 | 0.579 | 56 | 0.74 | 0.48 | 1.16 | 0.186 |
b) BC patients with coexisting AD | ||||||||||
All patients. N=1580 and N=1433 | ||||||||||
N | HR | 95% CI for HR | p-value | |||||||
AD adjusted for: | Lower | Upper | ||||||||
Age at diagnosis | 122 | 0.90 | 0.48 | 1.16 | 0.460 | |||||
Age at diagnosis, TNM-stage | 115 | 0.90 | 0.69 | 1.20 | 0.480 | |||||
Patients younger than 65 years at diagnosis of BC. N=1071 | Patients younger than 50 years at diagnosis of BC. N=500 | |||||||||
N | HR | 95% CI for HR | p-value | N | HR | 95% CI for HR | p-value | |||
AD adjusted for: | Lower | Upper | Lower | Upper | ||||||
Age at diagnosis, TNM-stage | 80 | 0.95 | 0.66 | 1.36 | 0.773 | 29 | 0.81 | 0.45 | 1.45 | 0.472 |
c) BC patients with coexisting HS | ||||||||||
All patients included. N= 1632 and N=1363 | ||||||||||
N | HR | 95% CI for HR | p-value | |||||||
HS adjusted for: | Lower | Upper | ||||||||
Age at diagnosis | 72 | 0.85 | 0.60 | 1.23 | 0.388 | |||||
Age at diagnosis, TNM-stage | 70 | 0.93 | 0.64 | 1.34 | 0.691 | |||||
Patients younger than 65 years at diagnosis of BC. N=1101 | Patients younger than 50 years at diagnosis of BC. N=502 | |||||||||
N | HR | 95% CI for HR | p-value | N | HR | 95% CI for HR | p-value | |||
HS adjusted for: | Lower | Upper | Lower | Upper | ||||||
Age at diagnosis, TNM-stage | 50 | 0.86 | 0.54 | 1.37 | 0.524 | 27 | 0.69 | 0.36 | 1.33 | 0.269 |